ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $206,828 | -96.8% | 5,800 | -95.9% | 0.00% | -96.9% |
Q1 2022 | $6,563,000 | -69.1% | 142,700 | -55.5% | 0.03% | -69.8% |
Q4 2021 | $21,257,000 | -57.3% | 320,617 | -59.8% | 0.11% | -54.3% |
Q3 2021 | $49,730,000 | +64.5% | 796,578 | +118.2% | 0.23% | +88.6% |
Q2 2021 | $30,229,000 | +164.4% | 365,000 | +111.7% | 0.12% | +115.8% |
Q1 2021 | $11,435,000 | +120.5% | 172,454 | +155.1% | 0.06% | +83.9% |
Q4 2020 | $5,187,000 | -71.6% | 67,600 | -84.0% | 0.03% | -75.4% |
Q3 2020 | $18,240,000 | -47.2% | 423,600 | -47.0% | 0.13% | -54.5% |
Q2 2020 | $34,552,000 | +20.1% | 800,000 | -20.0% | 0.28% | +12.1% |
Q1 2020 | $28,770,000 | +353.6% | 1,000,000 | +900.0% | 0.25% | +474.4% |
Q4 2019 | $6,343,000 | -65.4% | 100,000 | -84.6% | 0.04% | -68.8% |
Q3 2019 | $18,317,000 | -65.4% | 650,000 | -67.5% | 0.14% | -60.0% |
Q2 2019 | $53,000,000 | +50.4% | 2,000,000 | +4.1% | 0.34% | +30.2% |
Q1 2019 | $35,243,000 | +89.2% | 1,920,609 | +28.0% | 0.26% | +93.4% |
Q4 2018 | $18,630,000 | – | 1,500,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |